By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday that its first-quarter revenues increased 7 percent year over year, led by its Clinical Diagnostics segment.

The Hercules, Calif.-based firm had total revenues of $485.1 million for the three-month period ended March 31, compared to $454.2 million for Q1 2010. On a currency-neutral basis, its revenues increased 5 percent. Bio-Rad beat analysts' consensus estimate for revenues of $482.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.